MedPath

Comparison of three drugs named metronidazole, tinidazole and secnidazole for effectiveness in patients of liver abscess

Phase 3
Conditions
Health Condition 1: K750- Abscess of liver
Registration Number
CTRI/2022/01/039430
Lead Sponsor
Dr BSA Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All consenting patients presenting to surgery opd/emergency in given duration of time with evidence of single liver abscess.

Exclusion Criteria

1.USG evidence of presence of multiple liver abscesses.

2.Clinical signs and symptoms of intraperitoneal rupture of abscess.

3.Very sick patient requiring ICU admission

4.Age <10 years or >60 years

5.Pregnant women

6.Patient with history of malignancy past or present

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the efficacy of Metronidazole vs Tinidazole vs Secnidazole in a triple arm randomised controlled trial study in patients of Amoebic Liver Abscess.The efficacy will be assessed by resolution of symptoms and signs like fever, abdominal pain, right hypochondrium tenderness and leucocytosis.Timepoint: At 1 month and 3 months from date of discharge
Secondary Outcome Measures
NameTimeMethod
1.To compare the incidence of complications like intra peritoneal rupture, pleural effusion, atelectasis <br/ ><br>2.To report drug related side effect like nausea, metallic taste, peripheral neuropathy, caecal perforation, colitis <br/ ><br>3.Patient Satisfaction Score <br/ ><br>Timepoint: At 1 month and 3 months from date of discharge
© Copyright 2025. All Rights Reserved by MedPath